Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
This product will be launched through Granules Consumer Health (GCH) division
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
_256_384.jpeg)
Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
The audit is a pre-approval inspection for three products filed from the facility
Marksans' OTC Famotidine Tablets USP are acid reducers
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
According to IQVIA sales data for the 12-month period ending December 2022, the Onglyza Tablets, 2.5 mg and 5 mg market achieved annual sales of approximately US $122.3 million
Subscribe To Our Newsletter & Stay Updated
